Lilly Ventures

Lilly Ventures is the venture capital arm of Eli Lilly and Company, responsible for life science investing in North America and Europe. Our primary goal is to facilitate the success of companies in our focus areas through early- to expansion-stage investments and value-adding resources. Our investment philosophy drives us to seek great companies with compelling life science innovations. We partner actively with the management teams of our portfolio companies to realize the potential of their technologies. Lilly Ventures makes investments to move the innovation needle in novel areas of science, extending to health tech, emerging platforms, and other impact initiatives. We deploy customized engagement models to co-invest with world-class syndicate partners and offer counsel and connections within our global network, all with the goal of maximizing your company’s scientific impact.